Dacarbazine/octreotate-lu-177-dota-tyr-3/streptozocinVarious toxicities: 6 case reports

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-016-20862-z
中图分类号
学科分类号
摘要
引用
收藏
页码:83 / 83
相关论文
共 50 条
  • [23] Comparison of [177Lu-DOTA0,Tyr3]octreotate and [177Lu-DOTA0,Tyr3]octreotide: which peptide is preferable for PRRT?
    J. P. Esser
    E. P. Krenning
    J. J. M. Teunissen
    P. P. M. Kooij
    A. L. H. van Gameren
    W. H. Bakker
    D. J. Kwekkeboom
    European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 1346 - 1351
  • [24] Effects of therapy with [177Lu-DOTA0-Tyr3] octreotate on endocrine function
    Teunissen, J. J. M.
    Krenning, E. P.
    De Jong, F. H.
    De Rijke, Y. B.
    De Herder, W. W.
    Feelders, R.
    Van Aken, M. O.
    Kwekkeboom, D. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S220 - S220
  • [25] Hypocalcaemia after treatment with [177Lu-DOTA0,Tyr3]octreotate
    Esther I. van Vliet
    Wouter W. de Herder
    Yolanda B. de Rijke
    M. Carola Zillikens
    Boen L. R. Kam
    Jaap J. M. Teunissen
    Robin P. Peeters
    Eric P. Krenning
    Dik J. Kwekkeboom
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 1843 - 1852
  • [27] Hypocalcaemia after treatment with [177Lu-DOTA0,Tyr3]octreotate
    van Vliet, Esther I.
    de Herder, Wouter W.
    de Rijke, Yolanda B.
    Zillikens, M. Carola
    Kam, Boen L. R.
    Teunissen, Jaap J. M.
    Peeters, Robin P.
    Krenning, Eric P.
    Kwekkeboom, Dik J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (12) : 1843 - 1852
  • [28] Comparison of [177Lu-DOTA0, Tyr3] octreotate and [177Lu- DOTA0, Tyr3] octreotide:: which peptide is preferable for PRRT?
    Esser, J. P.
    Krenning, E. P.
    Teunissen, J. J. M.
    Kooij, P. P. M.
    van Gameren, A. L. H.
    Bakker, W. H.
    Kwekkeboom, D. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (11) : 1346 - 1351